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PXPEDITED REVIEW
orrected QT Variability in Serial
lectrocardiograms in Long QT Syndrome
he Importance of the Maximum Corrected QT for Risk Stratification
lan Goldenberg, MD,* Jehu Mathew, BS,* Arthur J. Moss, MD,* Scott McNitt, MS,*
erick R. Peterson, PHD,† Wojciech Zareba, MD, PHD,* Jesaia Benhorin, MD,‡ Li Zhang, MD,§
. Michael Vincent, MD, FACC,§ Mark L. Andrews, BBS,* Jennifer L. Robinson, MS,*
rian Morray, BS*
ochester, New York; Jerusalem, Israel; and Salt Lake City, Utah
OBJECTIVES We evaluated the incremental prognostic information provided by multiple corrected QT
(QTc) measurements on serial electrocardiograms (ECGs) in patients with the inherited long
QT syndrome (LQTS).
BACKGROUND A baseline QTc of 500 ms has been shown to be associated with increased risk of cardiac
events among LQTS patients. However, the value of QTc measurements on follow-up ECGs
in risk assessment has not been determined.
METHODS The risk of a first LQTS-related cardiac event during adolescence was assessed in 375 patients
enrolled in the International LQTS Registry for whom serial follow-up ECGs were recorded
before age 10.
RESULTS The mean SD difference between the minimum and maximum QTc values on serial ECGs
recorded in study patients was 47  40 ms. The maximum QTc interval recorded before age
10 was the strongest predictor of cardiac events during adolescence (adjusted hazard ratio
[HR]  2.74; p  0.001). Other follow-up QTc measures, including the baseline, the mean,
and the most recent QTc interval recorded before age 10, were less significant risk factors.
After adjusting for the maximum QTc value during follow-up, no significant association
remained between the baseline QTc value and the risk of subsequent cardiac events (HR 
1.04; p  0.91).
CONCLUSIONS In LQTS patients, there is a considerable variability in QTc measures in serial follow-up
ECGs. The maximum QTc interval provides incremental prognostic information beyond the
baseline measurement. We suggest that risk stratification in LQTS patients should include
follow-up ECG data. (J Am Coll Cardiol 2006;48:1047–52) © 2006 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.06.033College of Cardiology Foundation
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wongenital long QT syndrome (LQTS) is a genetic disor-
er that leads to the prolongation of the cardiac action
otential duration and is clinically manifest by increased
uration of the heart rate-corrected QT (QTc) interval on
he surface electrocardiogram (ECG) (1–3).
See page 1053
A baseline QTc interval of 500 ms has been shown to
e associated with a high risk of cardiac events (syncope,
borted cardiac arrest, or LQTS-related death) in LQTS
atients (4–8). However, the relationship between the QTc
nterval duration and the risk of cardiac events in earlier
tudies was evaluated primarily for the first recorded ECG,
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ochester, New York; ‡Bikur Cholim Hospital, University of Jerusalem, Jerusalem,
srael; §Latter Day Saints Hospital, Salt Lake City, Utah; and the University of Utah
chool of Medicine, Salt Lake City, Utah. Supported in part by research grants
L-33843 and HL-51618 from the National Institutes of Health, Bethesda,
aryland.C
Manuscript received January 6, 2006; revised manuscript received February 13,
006, accepted March 6, 2006.nd the incremental prognostic information provided by
ollow-up ECGs has not been determined.
In the current study, we assessed the value of follow-up
CG data recorded before age 10 years in predicting
ubsequent cardiac events during adolescence, a time period
nown to be associated with a high rate of LQTS-related
vents (2).
ETHODS
tudy population. The study population was drawn from
he International LQTS Registry and involved subjects
rom proband-identified families diagnosed with LQTS by
rolonged QTc criteria for age and gender as previously
eported (4). The present analysis comprised 375 patients
or whom 2 ECGs were recorded before age 10 years and
ollow-up data on cardiac events that occurred between 10
nd 20 years of age were available.
ata collection and management. For each patient, data
n personal and family history, cardiac events, and therapy
ere systematically recorded at each visit or medical contact.
linical data were recorded on prospectively designed forms
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CG, therapeutic, and cardiac event information. Upon
nrollment in the Long QT Registry, a 12-lead ECG was
btained from each patient. From this first recorded ECG,
he duration of the QT interval was assessed from lead II (or
ead I or III if the QT interval could not be measured from
ead II) and corrected for heart rate using Bazett’s formula
9). Additional serial QTc recordings were obtained from
CGs recorded during follow-up contacts, usually at yearly
ntervals. Electrocardiograms were excluded from the anal-
sis if recorded within 1 month after a previous ECG or
ithin 1 month after an LQTS-related cardiac event. The
eported analyses used the LQTS analytic database version
3.
All subjects or their guardians provided informed consent
o inclusion in the registry and subsequent clinical studies.
Tc summary measures. To evaluate the prognostic im-
lications of follow-up ECG data, we examined the follow-
ng QTc summary measures: 1) the QTc value obtained
rom the first recorded ECG (baseline QTc); 2) the average
f all recorded QTc values before age 10 (mean QTc); 3) the
ighest QTc value obtained at any time before age 10
maximum QTc); and 4) the QTc value obtained from the
ast ECG recorded before age 10 (recent QTc). In the
rimary analysis, QTc summary measures were dichoto-
ized at 500 ms, a value shown in previous studies to be
ssociated with increased risk of cardiac events in LQTS
atients (4–8); to avoid bias created by the possibility that
he 500 ms threshold is not optimal for all of the summary
easures, an alternative analysis was carried out in which
ach QTc summary measure was dichotomized at its upper
ertile, resulting in an equal number of positive tests for each
Tc summary measure. In a secondary analysis, we assessed
he relationship between different QTc thresholds and the
isk of cardiac events in study patients.
Because the cube root Fridericia formula has been sug-
ested to reflect a more accurate correction factor than
azett’s formula in subjects with faster heart rates (10),
ncluding children, all QTc analyses were repeated using the
ridericia rate correction.
ardiac events and medical therapy during follow-up.
ata regarding LQTS-related cardiac events was prospec-
ively collected and included the date of unexplained syn-
ope, aborted cardiac arrest (ACA) requiring cardiac resus-
itation, and unexpected sudden death exclusive of a known
Abbreviations and Acronyms
ACA  aborted cardiac arrest
ECG  electrocardiogram
HR  hazard ratio
LQTS  long QT syndrome
QTc  corrected QTause before age 21 years. vIn the present analysis the end point was defined as the
ccurrence of a first cardiac event (syncope, ACA, or
QTS-related death) between 10 and 20 years of age.
Follow-up data regarding beta-blocker therapy included
he starting date, type of beta-blocker, and discontinuation
ate in case it occurred. Among patients who died, the
sage of a beta-blocker before death was determined retro-
pectively.
tatistical analysis. The distribution of the time to first
ardiac event during adolescence, stratified by QTc sum-
ary measures obtained before age 10, was estimated using
he Kaplan-Meier method.
Cox proportional hazards regression was used to deter-
ine the significant and independent contribution of each
Tc summary measure to the development of a first cardiac
vent during adolescence. Additional covariates in each
odel included time-dependent beta-blocker therapy, the
ccurrence of a nonfatal cardiac event before age 10 years,
nd the number of follow-up ECGs obtained before age 10
ears (considered as either a linear or a categoric [2, 3, or4
CGs] variable), and the age of the first recorded ECG.
he deviance (2 log likelihood) was used to determine and
ompare the fit of each QTc summary measure model, with
he model with the best fit having the lowest deviance.
In the analysis of the association between different QTc
hresholds and cardiac events, a number of variables repre-
enting QTc duration dichotomized at different values
from 480 ms to 540 ms at 10-ms intervals) were analyzed
o identify the best QTc threshold. A best subsets procedure
or proportional hazards regression was used to compare the
odel fit using the different QTc thresholds. All of these
odels included the covariates for time-dependent beta-
locker use, cardiac events before the age of 10 years, the
umber of recorded ECGs before age 10 years and the age
f the first recorded ECG.
A significance level of 0.05 was used for declaring
tatistical significance of 2-sided tests. The statistical soft-
are used for the analyses was SAS version 9.13 (SAS
nstitute, Cary, North Carolina).
ESULTS
aseline clinical and ECG characteristics and cardiac events
uring follow-up are shown in Table 1. Among the 375
tudy subjects, the proportion of boys and girls was similar
nd more than one-half were treated with beta-blockers
efore age 10 years. A total of 99 study patients were
enetically tested and identified as carriers of an LQTS
utation (LQT1: 55 patients; LQT2: 32 patients; LQT3:
1 patients; and LQT6: 1 patient).
Syncope occurred in 30% of patients before the age of 10
nd was the most frequent cardiac event during adolescence.
The QTc interval duration exhibited considerable varia-
ion when follow-up ECGs were evaluated. The mean 
D difference between the minimum and maximum QTc
alues recorded in study patients before age 10 years was 47
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September 5, 2006:1047–52 QTc Variability and Risk Stratification in LQTS40 ms, and the maximum QTc was longer than baseline,
ean, and recent QTc values by 24 ms, 28 ms, and 30 ms,
espectively. When QTc summary measures were dichoto-
ized at 500 ms, the maximum QTc measure was shown to
ndicate the highest proportion of patients with a value of
500 ms (41%), whereas the proportion of such patients
ndicated by baseline, mean, and recent QTc values of500
s was lower (25%, 23%, and 25%, respectively).
ssociation between QTc summary measures before age
0 years and cardiac events during adolescence. Adjusted
azard ratios (HRs) for cardiac events during adolescence
or each QTc summary measure dichotomized at 500 ms are
hown in Table 2A. After adjusting for time-dependent
eta-blocker therapy, cardiac events before age 10, the
umber of ECGs recorded before age 10, and the age of the
rst recorded ECG, baseline QTc of 500 ms was an
nsignificant risk factor for cardiac events during adoles-
ence, whereas follow-up QTc summary measures were
tronger and significant risk factors. Among the 4 QTc
ummary measures analyzed, a maximum QTc value of
500 ms was the most significant predictor of cardiac
vents during adolescence. Accordingly, model 3, in which
he maximum QTc summary measure was included as
ovariate, was shown to have the best fit (as defined by the
owest deviance [2 log likelihood]) of the 4 models (Table
A).
In an alternative analysis, each QTc summary measure
able 1. Baseline Clinical and ECG Characteristics Before Age
0 Years and Frequency of Cardiac Events During Adolescence
Parameter n  375
aseline clinical characteristics
Female gender, n (%) 176 (47%)
Beta-blocker before age 10 202 (54%)
Hearing loss, n (%) 13 (3%)
Syncope before age 10, n (%) 113 (30%)
ACA before age 10, n (%) 20 (5%)
CG data before age 10
Age of first recorded ECG, yrs (mean  SD) 4.2  3.3
Time interval between ECGs, yrs (mean  SD) 1.5  1.6
Number of ECGs (mean  SD) 3.8  2.8
Heart rate per ECG, beats/min (mean  SD)* 89  20.3
QTc summary measures (ms)
Baseline QTc (mean  SD) 471  56
Mean QTc (mean  SD) 467  48
Maximum QTc (mean  SD) 495  64
Recent QTc (mean  SD) 465  55
QTc 500 ms
Baseline, n (%) 95 (25%)
Mean, n (%) 85 (23%)
Maximum, n (%) 152 (41%)
Recent, n (%) 94 (25%)
vents during adolescence
Syncope, n (%) 54 (14%)
ACA, n (%) 4 (1%)
LQTS death, n (%) 12 (3%)
Value is given as the mean heart rate in all ECGs recorded before age 10.
ACA  aborted cardiac arrest; ECG  electrocardiogram/electrocardiographic;
QTS  long QT syndrome; QTc  corrected QT.as dichotomized at its upper tertile. Similar results were
wbtained (Table 2B), demonstrating that the maximum
Tc was the most significant risk predictor among the four
ummary measures. Notably, dichotomizing the QTc sum-
ary measures resulted in superior fit to the data (as
easured by the deviance), compared with entering sum-
ary QTc measures as continuous covariates, suggesting
hat an assumption of linearity on the log hazard scale is not
ell supported by the data.
To further evaluate the relative importance of baseline
nd follow-up QTc summary measures, we included two
Tc summary measures, dichotomized at the upper tertile,
n each Cox model, resulting in 6 different combinations of
Tc measures. Consistent results were demonstrated,
howing that when the maximum QTc was combined with
ach of the other 3 QTc summary measures, only the former
Tc parameter was associated with a significant increase in
he risk of cardiac events (maximum QTc  baseline QTc:
R  2.70 [p  0.006] and 1.04 [p  0.91], respectively;
aximum QTc  mean QTc: HR  2.54 [p  0.04] and
.11 [p  0.84], respectively; maximum QTc  recent
Tc: HR  3.28 [p  0.001] and 0.76 [p  0.41],
espectively). Accordingly, models including the maximum
Tc as one of the summary measures maintained the best
t for predicting subsequent cardiac events.
Similar results were obtained when QTc was calculated
sing the Fridericia formula (data not shown). However, the
able 2. Adjusted Hazard Ratios for Cardiac Events for the 4
Tc Summary Measures*
. Summary Measures Dichotomized at 500 ms
QTc Summary
Measures HR
95% Confidence
Interval p Value
odel 1:
Baseline QTc 1.53 0.88–2.68 0.13
odel 2:
Mean QTc 2.09 1.18–3.72 0.01
odel 3:†
Maximum QTc 2.74 1.52–4.85 0.001
odel 4:
Recent QTc 2.03 1.17–3.52 0.01
. Summary Measures Dichotomized at the Upper Tertile‡
QTc Summary
Measures HR
95% Confidence
Interval p Value
odel 1:
Baseline QTc 1.89 1.06–3.37 0.03
odel 2:
Mean QTc 2.22 1.05–4.66 0.04
odel 3:†
Maximum QTc 2.76 1.56–4.87 0.001
odel 4:
Recent QTc 1.21 0.67–2.21 0.52
Each QTc summary measure was included separately in a Cox model and was further
djusted for the following covariates: time-dependent beta-blocker therapy, cardiac
vents before age 10, the number of ECGs recorded before age 10 and the age of the
rst recorded ECG; similar results were obtained when the number of ECGs
ecorded before age 10 was categorized (2, 3 or 4 ECGs). Gender did not make a
ignificant contribution to outcome in the multivariate models. †Model with the best
t as defined by the lowest deviance (2 log likelihood). ‡Dichotomized QTc values
ere as follows: baseline, mean, and recent: 480 ms; maximum: 510 ms.
HR  hazard ratio; other abbreviations as in Table 1.
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QTc Variability and Risk Stratification in LQTS September 5, 2006:1047–52esults using Bazett’s formula fit the data better than those
sing the Fridericia formula.
Time-dependent analysis of the benefit of beta-blocker
herapy demonstrated an overall 54% reduction in the risk of
ardiac events during adolescence (p  0.01) and an 83%
isk reduction in patients with a maximum QTc duration of
500 ms (p  0.001; p value for maximum QTc 
eta-blocker therapy interaction  0.009).
Kaplan-Meier curves describing the probability of expe-
iencing a first cardiac event during adolescence demon-
trated that patients with a maximum QTc value of 500
s exhibited the highest rate of cardiac events, regardless of
he baseline QTc value (Fig. 1).
ffect of the number of follow-up ECGs on the association
etween QTc summary measures and cardiac events. The
umber of ECGs recorded before age 10 and the age of the
rst recorded ECG were not significant predictors of
ardiac events during adolescence in all multivariate models
HR  1.01 [p  0.73] and 1.01 [p  0.86], respectively,
n the model including a maximum QTc of 500 ms).
When the 4 QTc summary measures were analyzed
mong patients with 2 ECGs during follow-up (Table 3),
maximum QTc value of 500 ms recorded at any time
efore age 10 was consistently shown to be the most
owerful predictor of cardiac events during adolescence.
otably, increasing HRs for the association between the
aximum QTc interval and cardiac events were obtained
ith increasing number of ECGs during follow-up (Table
).
Tc threshold and the risk of cardiac events. A baseline
Tc of 500 ms has been shown in earlier analyses to
iscriminate between risk groups in LQTS patients (4–8).
igure 1. Kaplan-Meier estimates of the probability of a first cardiac even
orrected QT (QTc) measures: maximum QTc500 ms and baseline QTc
Tc 500 ms and baseline QTc 500 ms.e examined whether this QTc threshold was also consis-
lent for QTc intervals measured on follow-up ECGs. In
his analysis, QTc was dichotomized at different values (480
o 540 ms by 10-ms intervals), and the deviances for the
esulting separate multivariate Cox models were compared.
hen different thresholds of the maximum QTc were
een ages 10 and 20 years in patients with the following combinations of
ms; maximum QTc500 ms and baseline QTc500 ms; and maximum
able 3. Adjusted Hazard Ratios for Cardiac Events for the 4
Tc Summary Measures Dichotomized at 500 ms Among
atients In Whom 3 and 4 ECGs Were Recorded Before
ge 10*
QTc Summary
Measures HR
95% Confidence
Interval p Value
3 ECGs (n  211)
Model 1:
Baseline QTc 1.23 0.61–2.51 0.56
Model 2:
Mean QTc 1.47 0.72–3.00 0.29
Model 3:†
Maximum QTc 2.81 1.28–6.16 0.01
Model 4:
Recent QTc 1.65 0.82–3.30 0.16
4 ECGs (n  138)
Model 1:
Baseline QTc 1.62 0.66–3.96 0.29
Model 2:
Mean QTc 1.46 0.61–3.47 0.40
Model 3:†
Maximum QTc 3.61 1.38–9.41 0.009
Model 4:
Recent QTc 1.67 0.71–3.95 0.24
Findings in each model were adjusted for the additional covariates: time-dependent
eta-blocker therapy, cardiac events before age 10, the number of ECGs recorded
efore age 10 and the age of the first recorded ECG; similar results were obtained
hen the number of ECGs recorded before age 10 was categorized (2, 3 or 4
CGs). Gender did not make a significant contribution to outcome in the multivar-
ate models. †Model with the best fit as defined by the lowest deviance (2 logt betwikelihood).
Abbreviations as in Tables 1 and 2.
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September 5, 2006:1047–52 QTc Variability and Risk Stratification in LQTSnalyzed (Table 4), QTc interval durations of 500 ms and
510 ms before age 10 years were shown to be the strongest
redictors of cardiac events during adolescence.
Similar analyses were performed to identify the best QTc
hreshold for the baseline (480 ms), mean (480 ms), and
ost recent (530 ms) summary measures. Consistently, a
aximum QTc dichotomized at 500 ms maintained the
est fit for the study data (2 log likelihood  651)
ompared with the best threshold of the former 3 summary
easures (2 log likelihood  658, 655, and 654, respec-
ively). In addition, when the maximum QTc was combined
ith each of the other 3 QTc summary measures with these
hresholds, only the former QTc parameter was associated
ith a significant increase in the risk of cardiac events (data
ot shown).
ISCUSSION
e have shown that in patients with LQTS there is a
onsiderable variability in QTc interval duration when serial
CGs are recorded during follow-up. This time-dependent
hange in QTc duration is an important determinant of the
henotypic expression of the disease. The maximum QTc
uration measured at any time before age 10 was shown to
e the most powerful predictor of cardiac events during
dolescence, regardless of baseline, mean, or most recent
Tc values.
In recent years, numerous advances have been made in
he risk stratification of LQTS patients (4–8, 11–17). It has
een shown that a QTc interval duration of 500 ms is a
ajor risk factor for cardiac events in this population.
owever, earlier studies in which the association between
he QTc interval duration and the risk of cardiac events was
nalyzed were limited mostly to a single QTc value mea-
ured in the first recorded ECG (4–8,11–17). Such an
pproach precludes the possibility of analyzing the effect of
ime-dependent change in QTc values on the risk of
able 4. Adjusted HR for Cardiac Events of the Maximum
Tc Summary Measure, Dichotomized at Different QTc
ntervals*
Threshold (n  375) HR
95% Confidence
Interval p Value
aximum QTc 480 ms 1.83 0.98–3.45 0.06
aximum QTc 490 ms 2.04 1.12–3.73 0.02
aximum QTc 500 ms† 2.74 1.52–4.85 0.001
aximum QTc 510 ms† 2.76 1.56–4.87 0.001
aximum QTc 520 ms 2.35 1.35–4.11 0.002
aximum QTc 530 ms 2.41 1.37–4.26 0.002
aximum QTc 540 ms 2.33 1.31–4.12 0.004
A best subsets procedure was used to compare the model fit (see text); findings in
ach model were adjusted for the additional covariates: time-dependent beta-blocker
herapy, cardiac events before age 10, the number of ECGs recorded before age 10
nd the age of the first recorded ECG; similar results were obtained when the number
f ECGs recorded before age 10 was categorized (2, 3 or 4 ECGs). Gender did not
ake a significant contribution to outcome in the multivariate models. †Models with
he best fit as defined by the lowest deviance (2 log likelihood); models with
aximum QTc 500 ms and 510 ms yielded virtually identical deviances.
Abbreviations as in Tables 1 and 2.QTS-related cardiac events. In addition, QTc values seasured in the first recorded ECG in earlier studies were
ot necessarily determined before an event end point.
herefore, the interpretation of the association between
Tc duration and subsequent cardiac events in previous
eports may be limited by the lack of a consistent chronol-
gy between QTc measurements and events.
In the current study, we have evaluated the incremental
enefit of follow-up ECG data in the risk stratification of
QTS patients. Our results show that QTc values obtained
uring follow-up in LQTS patients are clinically important
nd better define subsequent risk of cardiac events than a
ingle baseline QTc value. In our analysis, the change in
Tc values was not age-related or linear. Rather, a QTc
nterval duration of 500 ms obtained at any earlier time
merged as the best indicator of risk. Therefore, LQTS
atients with a single recorded QTc value below this
hreshold, who are currently considered to be at a lower risk,
hould be continually assessed, because the phenotypic
xpression of this disease entity is dynamic and can change
t any time during follow-up. Notably, we have shown that
he improved risk stratification provided by obtaining the
aximum QTc value on follow-up ECGs can be further
mproved by increasing the number of recorded ECGs.
hus, risk stratification, based on QTc measurements,
hould use repeated follow-up ECG QTc measures.
The incremental prognostic information obtained by
ecording follow-up QTc data draws attention to the
ariability present in this ECG parameter. The changes over
ime seen in the QTc interval highlight the fact that LQTS
s a genetic disorder with variable expressivity. Increased
Tc variability reflects an exaggeration of the normally
eterogeneous process of ventricular repolarization. Conse-
uently, as the cardiac action potential is prolonged, myo-
ytes become vulnerable to re-entrant currents that can
rigger early after-depolarizations and subsequent torsades
e pointes tachyarrhythmias (18). This varied clinical ex-
ression, which has been shown in other studies (19,20),
xplains the need to examine multiple ECGs to properly
ssess this dynamic ECG parameter. A maximum QTc of
500 ms, despite lower baseline values, may signify an
xtremely heterogeneous repolarization state in LQTS pa-
ients which places patients with this ECG manifestation at
high risk for an arrhythmic event.
The focus of the present study was to evaluate the risk
ssociated with QTc data. However, it should be noted that
ther risk factors, including a history of prior syncope, age,
ender, and genotype, are associated with events in LQTS
atients and may contribute to the development of fatal or
onfatal events independently of the QTc. In the current
tudy a maximum QTc duration of 480 ms was associated
ith a meaningful, although of a lesser magnitude than with
he 500-ms threshold, increase in the risk of cardiac events.
herefore, a comprehensive clinical risk assessment is espe-
ially important when borderline QTc increments are mea-
ured during follow-up.
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QTc Variability and Risk Stratification in LQTS September 5, 2006:1047–52The current data suggest that when QTc interval dura-
ion exceeds 500 ms during follow-up, even among LQTS
atients in whom prior ECGs recorded lower values,
rimary therapy of this genetic disorder should be consid-
red. Notably, treatment with beta-blockers was associated
ith a highly significant 83% reduction in the risk of cardiac
vents in patients with a maximum QTc of 500 ms.
herefore, initiation of beta-blocker therapy should be
onsidered in all patients in whom increasing QTc dura-
ions are measured in serial ECGs, and alternative therapies,
ncluding primary defibrillator implantation, may be war-
anted in patients with increasing QTc values and recurrent
onfatal events despite beta-blocker therapy.
tudy limitations. In the current study we analyzed the
isk of cardiac events during adolescence, because this time
eriod has been shown to be associated with a relatively high rate
f LQTS-related events. The generalizability of our findings to
ther age groups should be evaluated in future studies.
Patients were included in the study if 2 ECGs were
ecorded before age 10 years. Therefore, the study cohort
ay represent a higher-risk LQTS subset. This potential
ias was perhaps partially ameliorated by adjusting for
arlier cardiac events, the number of recorded ECGs before
ge 10 years, and the age of the first recorded ECG in the
ultivariate Cox regression models.
Owing to the relatively small number of study patients
ho were genotyped, the relationship between specific
QTS genotypes and the prognostic implication of long-
erm QTc change was not assessed. Genotype has been
hown to affect the clinical course of LQTS (1–5,13–17),
nd future efforts to relate genetic data to long-term ECG
ollow-up may improve risk assessment of LQTS patients.
Forty-one percent of the study patients had a maximum
Tc of 500 ms, whereas only 25% of the patients had a
aseline QTc of 500 ms. We have shown that these
ncremental ECG data during childhood have important
rognostic implications during adolescence, which are even
ore important than the information obtained from the last
ecorded ECG before adolescence. However, we did not
valuate the effect of time-dependent changes in QTc
uration during adolescence on the risk of subsequent
ardiac events. It is possible that QTc decrements reported
n boys during this time-period (13) are also associated with
reduction in risk. The current data suggest that QTc
hould be evaluated as a time-dependent risk factor in future
tudies of LQTS patients.
onclusions. We have shown that in LQTS patients, a
Tc duration of 500 ms at any time during follow-up is
ssociated with an increased risk of subsequent cardiac
vents, regardless of the baseline QTc value. Our findings
uggest that QTc data from follow-up ECGs have impor-
ant incremental prognostic value and should be incorpo-
ated into the risk stratification of LQTS patients in view of
he dynamic phenotypic expression of this genetic disorder.cknowledgments
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